Benjamin C Warf Selected Research

cytidylyl-(3'-5')-cytidine (CpC)

1/2022	Improving Infant Hydrocephalus Outcomes in Uganda: A Longitudinal Prospective Study Protocol for Predicting Developmental Outcomes and Identifying Patients at Risk for Early Treatment Failure after ETV/CPC.
1/2019	Reversible intracranial hypertension following treatment of an extracranial vascular malformation: case report.
12/2017	Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda.
5/2017	Comparative effectiveness of flexible versus rigid neuroendoscopy for endoscopic third ventriculostomy and choroid plexus cauterization: a propensity score-matched cohort and survival analysis.
4/2015	Reopening of an obstructed third ventriculostomy: long-term success and factors affecting outcome in 215 infants.
11/2014	Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment for infant hydrocephalus: a prospective North American series.
6/2013	Congenital idiopathic hydrocephalus of infancy: the results of treatment by endoscopic third ventriculostomy with or without choroid plexus cauterization and suggestions for how it works.
12/2012	Shunt survival after failed endoscopic treatment of hydrocephalus.
8/2012	Long-term outcome for endoscopic third ventriculostomy alone or in combination with choroid plexus cauterization for congenital aqueductal stenosis in African infants.
10/2011	Hydrocephalus associated with neural tube defects: characteristics, management, and outcome in sub-Saharan Africa.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin C Warf Research Topics

Disease

27	Hydrocephalus (Hydrocephaly) 01/2022 - 01/2005
5	Meningomyelocele (Myelomeningocele) 12/2021 - 12/2005
5	Cicatrix (Scar) 01/2018 - 02/2010
4	Spinal Dysraphism (Spina Bifida) 12/2021 - 11/2008
3	Infections 12/2012 - 01/2011
2	Neural Tube Defects (Exencephaly) 12/2021 - 10/2011
2	Dandy-Walker Syndrome (Dandy Walker Malformation) 01/2019 - 10/2011
1	Umbilical Hernia (Omphalocele) 01/2022
1	Arsenic Poisoning 12/2021
1	Meningocele 12/2021
1	Inflammation (Inflammations) 01/2020
1	Hyperplasia 01/2020
1	Arteriovenous Fistula 01/2019
1	Intracranial Hypertension 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Hydronephrosis 01/2018
1	Critical Illness (Critically Ill) 01/2016
1	Pathologic Constriction (Stenosis) 08/2012
1	Hemorrhage 07/2011

Drug/Important Bio-Agent (IBA)

15	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022 - 12/2005
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2021 - 06/2017
1	VanadiumIBA 12/2021
1	MetalsIBA 12/2021
1	CobaltIBA 12/2021
1	SeleniumIBA 12/2021
1	ChromiumIBA 12/2021
1	ZincIBA 12/2021
1	AluminumIBA 12/2021
1	IronIBA 12/2021
1	ArsenicIBA 12/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	CytokinesIBA 01/2020
1	boldenone undecylenate (Equipoise)IBA 01/2019
1	CreatinineIBA 01/2018
1	Ribosomal DNA (rDNA)IBA 01/2011

Therapy/Procedure

20	Ventriculostomy 01/2022 - 01/2005
17	Cautery 01/2022 - 01/2007
4	Ventriculoperitoneal Shunt 01/2022 - 05/2005
2	Therapeutics 01/2016 - 02/2014
1	Colostomy 01/2022
1	Catheters 01/2019
1	Neuroendoscopes 05/2017